These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34707492)

  • 1. Parkinson's Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron.
    Han J; Fan Y; Wu P; Huang Z; Li X; Zhao L; Ji Y; Zhu M
    Front Aging Neurosci; 2021; 13():743754. PubMed ID: 34707492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-Beta (Aβ) Plaques Promote Seeding and Spreading of Alpha-Synuclein and Tau in a Mouse Model of Lewy Body Disorders with Aβ Pathology.
    Bassil F; Brown HJ; Pattabhiraman S; Iwasyk JE; Maghames CM; Meymand ES; Cox TO; Riddle DM; Zhang B; Trojanowski JQ; Lee VM
    Neuron; 2020 Jan; 105(2):260-275.e6. PubMed ID: 31759806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal TNFα, Not α-Syn, Underlies PDD-Like Disease Progression in IFNβ-KO Mice.
    Villanueva EB; Tresse E; Liu Y; Duarte JN; Jimenez-Duran G; Ejlerskov P; Kretz O; Loreth D; Goldmann T; Prinz M; Issazadeh-Navikas S
    Ann Neurol; 2021 Nov; 90(5):789-807. PubMed ID: 34476836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of the interplay between α-synuclein and Tau in regulating pathological amyloid aggregation.
    Lu J; Zhang S; Ma X; Jia C; Liu Z; Huang C; Liu C; Li D
    J Biol Chem; 2020 May; 295(21):7470-7480. PubMed ID: 32291284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson's Disease Dementia.
    Li M; Fan Y; Li Q; Wang X; Zhao L; Zhu M
    Oxid Med Cell Longev; 2022; 2022():7165387. PubMed ID: 36246407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between APOE Variants, Tau and α-Synuclein.
    Rodriguez-Vieitez E; Nielsen HM
    Adv Exp Med Biol; 2019; 1184():177-186. PubMed ID: 32096038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of NOX4 in Parkinson's Disease with Dementia.
    Choi DH; Choi IA; Lee CS; Yun JH; Lee J
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autophagic activity of piperine on small intestine in dementia model mice with Parkinson's disease].
    Li-Ping H; Xiao-Qin Z; Qing L; Qin-Xin Z; Min-Zhen D
    Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(21):5238-5247. PubMed ID: 33350241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia.
    Yang L; Wang H; Liu L; Xie A
    Front Neurosci; 2018; 12():73. PubMed ID: 29515352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of physical exercise on β-amyloid, α-synuclein and tau accumulation: an in vitro model of oxidative stress in human red blood cells.
    Iofrida C; Daniele S; Pietrobono D; Fusi J; Galetta F; Trincavelli ML; Bonuccelli U; Franzoni F; Martini C
    Arch Ital Biol; 2017 Jul; 155(1-2):33-42. PubMed ID: 28715596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Targeting of Monomeric Tau and α-Synuclein Aggregation: A New Multitarget Therapeutic Strategy for Neurodegeneration.
    Gabr MT; Peccati F
    ACS Chem Neurosci; 2020 Jul; 11(14):2051-2057. PubMed ID: 32579329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity.
    Daniele S; Frosini D; Pietrobono D; Petrozzi L; Lo Gerfo A; Baldacci F; Fusi J; Giacomelli C; Siciliano G; Trincavelli ML; Franzoni F; Ceravolo R; Martini C; Bonuccelli U
    Front Mol Neurosci; 2018; 11():53. PubMed ID: 29520218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.
    Irwin DJ; Lee VM; Trojanowski JQ
    Nat Rev Neurosci; 2013 Sep; 14(9):626-36. PubMed ID: 23900411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of synucleins in Alzheimer's disease.
    Crews L; Tsigelny I; Hashimoto M; Masliah E
    Neurotox Res; 2009 Oct; 16(3):306-17. PubMed ID: 19551456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders.
    Irwin DJ; Hurtig HI
    J Alzheimers Dis Parkinsonism; 2018; 8(4):. PubMed ID: 30473927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
    Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury.
    Sánchez Campos S; Alza NP; Salvador GA
    Arch Biochem Biophys; 2018 Oct; 655():43-54. PubMed ID: 30098984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia.
    Wills J; Jones J; Haggerty T; Duka V; Joyce JN; Sidhu A
    Exp Neurol; 2010 Sep; 225(1):210-8. PubMed ID: 20599975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
    Badiola N; de Oliveira RM; Herrera F; Guardia-Laguarta C; Gonçalves SA; Pera M; Suárez-Calvet M; Clarimon J; Outeiro TF; Lleó A
    PLoS One; 2011; 6(10):e26609. PubMed ID: 22039514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.